About Us - Beijing North Biotechnology Research Institute Co., Ltd

About Us

Company Profile

Our mission is to provide high-quality products and services for human health

Beijing North Biotechnology Research Institute Co., Ltd. (hereinafter referred to as "North Biotechnology") was established in 1985 and is a wholly-owned subsidiary of China National Nuclear Corporation's CNNC Health Investment Co., Ltd. The company is committed to providing high-quality products and services for human health, and upholds the mission of focusing on in vitro diagnostics and serving human health. With 40 years of deep cultivation in the field of in vitro diagnostics (IVD), it is one of the earliest institutions in China engaged in the research and development, production, sales, and testing of immunological diagnostic reagents, and is a national high-tech enterprise.

Northern Biotech is closely following the "One Two Three" development strategy of CNNC Health, focusing on the in vitro diagnostic industry, establishing regional medical testing centers, creating commercial innovation platforms, and striving to become a well-known comprehensive service provider in the in vitro diagnostic industry in China. We have nearly 200 product registration certificates, and our production workshop has passed national GMP and ISO13485 certifications. We can produce more than 300 types of in vitro diagnostic reagents such as radioimmunoassay, enzyme-linked immunosorbent assay, colloidal gold, chemiluminescence, etc.

Our business covers multiple countries and regions around the world, and we have rich experience in production and operation. Our industrial development and expansion capabilities are sufficient. At the same time, the company actively expands its third-party medical testing business, with three independent third-party medical testing laboratories in Chengdu, Wuhan, and Hefei, and one diagnostic reagent production and research and development enterprise and one commercial innovation circulation platform in Shanghai. This lays a solid foundation for the company to build a fully segmented enterprise cluster that integrates the research and development, production, sales, and regional medical testing services of collective external diagnostic products.

Entering a new stage of development, Northern Biotech will aim to become a leading domestic enterprise in radiation immunology, a domestic alternative R&D platform for in vitro diagnostics, and a regional chain service provider for medical testing services. Keeping in mind its mission, we will break through innovation, continuously improve our independent R&D capabilities and quality control levels, and create a new highland for the development of the domestic in vitro diagnostics industry, contributing new strength to safeguarding people's lives and health!

1985

year

The company was established in

163

Product Registration Certificate

300

Multiple in vitro diagnostic reagent products

family

Covering medical testing, diagnostic reagents, and commercial applications

Subsidiaries engaged in innovative circulation and other businesses

Subsidiary

Wuhan CNNC Zhongtong Lanbo Medical Laboratory Co., Ltd

Wuhan CNNC Zhongtong Lanbo Medical Laboratory Co., Ltd. (hereinafter referred to as "Wuhan Lanbo") is affiliated with Beijing North Biotechnology Research Institute Co., Ltd., a subsidiary of CNNC Health Investment Co., Ltd. It is an independent medical laboratory that integrates clinical laboratory services, clinical laboratory teaching, and scientific research cooperation.

Wuhan Lanbo has a chemiluminescence immunoassay laboratory, PCR laboratory, biochemistry laboratory, enzyme immunoassay laboratory, microbiology laboratory, special testing laboratory, trace element laboratory, and pathology laboratory. We provide approximately 600 laboratory tests and numerous advanced research platforms to clinical practice, providing various scientific monitoring services for researchers. And since its establishment, it has always been committed to the mission of "sharing medical resources and serving public health", targeting various levels of medical and health institutions such as scientific research, comprehensive and specialized hospitals, community health service stations, physical examination centers, disease control centers, etc., with providing medical diagnosis services outsourcing as the core, committed to the integration of clinical medical diagnosis and clinical application, effectively reducing the business costs of medical institutions at all levels, improving the quality of diagnosis and treatment, achieving a win-win situation with medical institutions, combining advantageous medical resources, strong cooperation, and serving Hubei Province and the central region.

Since its establishment, Wuhan Lanbo has been applying the internationally recognized medical laboratory accreditation standard - ISO15189 international standard - to all processes of Wuhan Lanbo, covering all 15 management elements and 8 technical elements related to inspection quality before, during, and after the inspection. The strict quality management measures have received unanimous praise from experts of the National Accreditation Service for Conformity Assessment. And it has successfully passed the on-site audit by ISO15189 experts in July 2024.

Subsidiary

CNNC Zhongtong Lanbo (Chengdu) Medical Laboratory Co., Ltd

CNNC Zhongtong Lanbo (Chengdu) Medical Laboratory Co., Ltd. (referred to as Chengdu Lanbo) is affiliated with Beijing North Biotechnology Research Institute Co., Ltd., a subsidiary of CNNC Health Investment Co., Ltd. It is a clinical medical laboratory center that integrates clinical laboratory services, scientific research and development, and clinical trial services.

Since its establishment, Chengdu Lanbo has strengthened internal management, expanded its market, and comprehensively implemented a refined management model. Relying on professional technical strength and comprehensive high-quality services, it has continuously developed and grown in the market, applying the internationally recognized medical laboratory accreditation standard - ISO15189 international standard - to all laboratory workflows, strictly operating in accordance with the IS015189 quality system to ensure testing quality. Committed to establishing the most extensive, authoritative, and efficient medical testing platform in the Southwest region, serving the entire Sichuan and Chongqing surrounding areas, and standing out from the participating enterprises with outstanding innovation capabilities and high growth development models in 2021, it was listed on the 2021 High tech Zone Gazelle Enterprise List and awarded the national "High tech Enterprise" certification in 2022.

At present, Chengdu Lanbo has a genetic testing center, a medical pathology center, a genetic testing center, a special testing center, and laboratories for biochemistry, immunology, microbiology, trace elements, etc. It has 40 professional technicians and more than 100 testing equipment, which can provide nearly 1500 testing services for clinical practice. The company's main business is a medical entity that integrates clinical laboratory services, scientific research and development, and clinical trial services. It has hired well-known experts and professors in the field of medical laboratory testing at home and abroad as technical consultants to ensure the quality of testing.

Subsidiary

Hefei CNNC Zhongtong Lanbo Medical Laboratory Co., Ltd

Hefei CNNC Zhongtong Lanbo Medical Laboratory Co., Ltd. was registered and established on May 30, 2019, and officially began operations after obtaining a medical institution practice license on December 25, 2020. In November 2023, it was approved as a high-tech enterprise in Anhui Province, with 236 existing customers involved in 11 prefecture level cities within Anhui Province.

Hefei Lanbo is affiliated with Beijing North Biotechnology Research Institute Co., Ltd., a subsidiary of China National Nuclear Health Investment Co., Ltd. The laboratory is established according to international advanced medical laboratory standards, with an area of 2844 square meters. We have established a distinctive national chain testing platform internally, providing a one-stop solution for clinical medical testing and becoming one of the professional clinical medical testing institutions in Anhui Province.

Hefei Lanbo relies on the reserve of professional talents in the group and the international advanced management level in the industry. With ISO15189 quality management system as the standard, it adheres to the corporate mission of "sharing medical resources and serving public health". Zhuoli provides more reassuring, professional, and high-quality testing services for clinical medical institutions in Anhui Province. Currently, the laboratory can provide more than 1000 testing services.

Subsidiary

Boshi Healthcare (Shanghai) Co., Ltd

Boshi Healthcare (Shanghai) Co., Ltd. was registered and established on November 25, 2022. Beijing North Biotechnology Research Institute Co., Ltd., a subsidiary of CNNC Health Investment Co., Ltd., has a registered capital of 10 million yuan.

The company has the qualifications for Class II medical device registration and Class III medical device business license. The company mainly engages in the sales of Class I, II, and III 6840 in vitro diagnostic equipment and reagent consumables. The main customer groups include medical institutions, third-party laboratories, and medium to large central laboratories.

Boshi Health is committed to providing customers with high-quality products and services, including comprehensive integrated solutions such as laboratory design, equipment procurement, installation and commissioning, training, and after-sales service. We have established cooperative relationships with hundreds of public medical institutions, testing centers, independent medical testing laboratories, etc. nationwide, with tertiary hospitals accounting for nearly 30%.

Subsidiary

Shanghai Boshi Diagnostic Products Co., Ltd

Shanghai Boshi Diagnostic Products Co., Ltd. was established on September 4, 2008, and is affiliated with Beijing North Biotechnology Research Institute Co., Ltd., a subsidiary of CNNC Health Investment Co., Ltd., with a registered capital of 61.22449 million yuan.
Boshi Diagnostics specializes in the research and development, production, and sales of Class I medical devices, as well as the sales of Class II and Class III medical devices. The company strictly adheres to the Regulations on the Supervision and Administration of Medical Devices, has passed ISO9001 and 13485 quality system certifications, and has nearly a hundred product registration certificates. Our main products cover multiple varieties such as medical consumables, in vitro diagnostic equipment, and reagents, which are widely used in various medical institutions, third-party laboratories, and medium to large central laboratories.

Since its establishment, the company has always adhered to the concept of "service first, customer first", continuously expanding new business models and sales channels, and striving to promote the continuous and in-depth development of the in vitro diagnostic product line.

Corporate Culture

Corporate Purpose

Provide high-quality products and services for human health

Corporate Mission

Focusing on in vitro diagnostics to serve human health

Quality Culture

Cultivate quality genes, pursue technological progress, and achieve customer expectations with high-quality products

Development Goals

Focusing on the in vitro diagnostic industry, with scientific research and medical testing as the two wings, striving to build

To become a well-known comprehensive service provider in the in vitro diagnostic industry in China.

Development History

Beijing North Biotechnology Research Institute Co., Ltd

Phone: 010-87504050

Email: bfsw@cnnchic.com

Address: No. 20, Panjiamiao Jia, Fengtai District, Beijing

Wuhan CNNC Zhongtong Lanbo Medical Laboratory Co., Ltd

Telephone:027-87003295

Email: whlb@cnnchic.com

Address: Room C11-1501-1601, Wuhan Software New City Phase II, No. 8 Huacheng Avenue, Donghu New Technology Development Zone, Wuhan City

CNNC Zhongtong Lanbo (Chengdu) Medical Laboratory Co., Ltd

Phone: 028-69762601

Email: cdlb@cnnchic.com

Address: 9-10/F, Building 4, Haite International Plaza, High tech Zone, Chengdu

Hefei CNNC Zhongtong Lanbo Medical Laboratory Co., Ltd

Phone: 0551-69110706, 0551-69110707

Email: hflb@cnnchic.com

Address: Floors 1-4, Building 6, Luyang Big Data Industrial Park, No. 868 Qinghe Road, Luyang Industrial Park, Luyang District, Hefei City, Anhui Province

Boshi Healthcare (Shanghai) Co., Ltd

Phone: 4008207669

Email: bshealthcare@cnnchic.com

Address: Building 3, 539 Huancheng North Road, Fengxian District, Shanghai

Shanghai Boshi Diagnostic Products Co., Ltd

Phone: 021-67181810

Email: bsdiagnostics@cnnchic.com

Address: Floors 1-3, Building B3, No. 1099 Huancheng North Road, Fengxian District, Shanghai

Friendship link:

Beijing Municipal Drug Administration

State Administration for Market Regulation

National Drug Administration

Beijing Municipal Administration for Market Regulation

Beijing Municipal Government Service Network

Technical Support: Xunxiang Technology